Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1987-06-26
1988-04-19
Gerstl, Robert
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514369, 546165, 546166, 546167, 546280, 548183, C07D41710, C07D27734, A61K 31425, A61K 3147
Patent
active
047389729
ABSTRACT:
Hypoglycemic 5-[1-(5,6,7,8-tetrahydro-2-napthyl-; 1,2,3,4-tetrahydro-6-quinolyl-; 2-indanyl-; and 2-indolyl)alkyl]thiazolidine-2,4-dione derivatives, pharmaceutically acceptable salts thereof, and a method for their use in the treatment of hyperglycemic mammals.
REFERENCES:
patent: 4340605 (1982-07-01), Kawamatsu et al.
patent: 4376777 (1983-03-01), Kawamatsu et al.
patent: 4461902 (1984-07-01), Kawamatsu et al.
patent: 4572912 (1986-02-01), Yoshioka
Eggler James F.
Holland Gerald F.
Johnson Michael R.
Volkmann Robert A.
Blackwood Robert K.
Frost Albert E.
Gerstl Robert
Pfizer Inc.
Richardson Peter C.
LandOfFree
Hypoglycemic thiazolidinediones does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Hypoglycemic thiazolidinediones, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hypoglycemic thiazolidinediones will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2175510